Less stress, more success? Oncological implications of surgery-induced oxidative stress

Gut

Volumn 62, Issue 3, 2013, Pages 461-470

  O'Leary, D P ^a,b   Wang, J H ^a   Cotter, T G ^b   Redmond, H P ^a  

^a University College Cork and INFANT Centre   (Ireland)

^b UNIVERSITY COLLEGE CORK   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GROWTH FACTOR; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1BETA; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 1; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1; VASCULOTROPIN;

ACUTE PHASE RESPONSE; ANGIOGENESIS; ARTICLE; CELL ADHESION; CELL DEATH; CELL INVASION; CELL PROLIFERATION; CELL SURVIVAL; COLORECTAL CANCER; ENZYME ACTIVATION; HUMAN; INTRACELLULAR SIGNALING; LAPAROSCOPIC SURGERY; LIVER METASTASIS; MINIMALLY INVASIVE SURGERY; OXIDATIVE STRESS; PERITONEUM METASTASIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SURGERY-INDUCED OXIDATIVE STRESS; SURGICAL INJURY; TUMOR CELL; TUMOR GROWTH; TUMOR RECURRENCE;

DIGESTIVE SYSTEM SURGICAL PROCEDURES; DRUG DELIVERY SYSTEMS; GASTROINTESTINAL NEOPLASMS; HUMANS; OXIDATION-REDUCTION; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION;

EID: 84873407904     PISSN: 00175749     EISSN: 14683288     Source Type: Journal    
DOI: 10.1136/gutjnl-2011-300948     Document Type: Article

References (181)

1. Bulkley GB. The role of oxygen free radicals in human disease processes. Surgery 1983;94:407e11.
2. Billing AG, Jochum M, Frohlich D, et al. Oxidative autoaggression by phagocytes in human peritonitis. Eur J Clin Invest 1997;27:1030e7.
3. Gül N, B̈ogels M, Grewal S, et al. Surgery-induced reactive oxygen species enhance colon carcinoma cell binding by disrupting the liver endothelial cell lining. Gut 2011;60:1076e86.
4. Toledano MB, Planson AG, Delaunay-Moisan A. Reining in H (2) O (2) for safe signaling. Cell 2010;140:454e6.
5. Rhee SG. H2O2, a necessary evil for cell signalling. Science 2006;312:1882e3.
6. Gough DR, Cotter TG. Hydrogen peroxide: a Jekyll and Hyde signalling molecule. Cell Death Dis. 2011;2:e213.
7. Cerruti PA. Prooxidant states and tumor promotion. Science 1985;227:375e81.
8. Kensler TW, Taffe BG. Free radicals in tumor promotion. Adv Free Radic Biol Med 1986;2:347e87.
9. Fricova J, Stopka P, Krizova J, et al. The effect of laparotomy on hydroxyl radicals, singlet oxygen and antioxidants measured by EPR method in the tails of rats. Neuro Endocrinol Lett 2009;30:373e6.
10. Ten Kate M, Van Der Wal J B C, Sluiter W, et al. The role of superoxide anions in the development of distant tumour recurrence. Br J Cancer 2006;95:1497e503.
11. Nishizaki C, Nishikawa M, Yata T, et al. Inhibition of surgical trauma-enhanced peritoneal dissemination of tumor cells by human catalase derivatives in mice. Free Radic Biol Med 2011;51:773e9.
12. Hirai T, Matsumoto H, Yamashita K, et al. Surgical oncotaxisdexcessive surgical stress and postoperative complications contribute to enhancing tumor metastasis, resulting in a poor prognosis for cancer patients. Ann Thorac Cardiovasc Surg 2005;11:4e6.
13. Coffey JC, Wang JH, Smith MJ, et al. Excisional surgery for cancer cure: therapy at a cost. Lancet Oncol 2003;4:760e8.
14. Van Der Bij GJ, Oosterling SJ, Beelen RH, et al. The perioperative period is an underutilized window of therapeutic opportunity in patients with colorectal cancer. Ann Surg 2009;249:727e34.
15. Coffey JC, Smith MJ, Wang JH, et al. Cancer surgery: risks and opportunities. Bioessays 2006;28:433e7.
16. Lee JW, Shahzad M M K, Lin YG, et al. Surgical stress promotes tumor growth in ovarian carcinoma. Clin Cancer Res 2009;15:2695e702.
17. Glasner A, Avraham R, Rosenne E, et al. Improving survival rates in two models of spontaneous postoperative metastasis in mice by combined administration of a b-adrenergic antagonist and a cyclooxygenase-2 inhibitor. J Immunol 2010;184:2449e57.
18. Allendorf JD, Bessler M, Horvath KD, et al. Increased tumor establishment and growth after open vs laparoscopic bowel resection in mice. Surg Endosc 1998;12:1035e8.
19. Lee SW, Gleason N, Blanco I, et al. Higher colon cancer tumor proliferative index and lower tumor cell death rate in mice undergoing laparotomy versus insufflation. Surg Endosc 2002;16:36e9.
20. Juhasz A, Ge Y, Markel S, et al. Expression of NADPH oxidase homologues and accessory genes in human cancer cell lines, tumours and adjacent normal tissues. Free Radic Res 2009;43:523e32.
21. Ushio-Fukai M, Urao N. Novel role of NADPH oxidase in angiogenesis and stem/progenitor cell function. Antioxid Redox Signal 2009;11:2517e33.
22. Sancho P, Fabregat I. NADPH oxidase NOX1 controls autocrine growth of liver tumor cells through up-regulation of the epidermal growth factor receptor pathway. J Biol Chem 2010;285:24815e24.
23. Szatrowski TP, Nathan CF. Production of large amounts of hydrogen peroxide by human tumor cells. Cancer Res 1991;51:794e8.
24. Kumar B, Koul S, Khandrika L, et al. Oxidative stress is inherent in prostate cancer cells and is required for aggressive phenotype. Cancer Res 2008;68:1777e85.
25. Shi DY, Xie FZ, Zhai C, et al. The role of cellular oxidative stress in regulating glycolysis energy metabolism in hepatoma cells. Mol Cancer 2009;8:32.
26. 2 ratio and confers anoikis resistance to tumors. Cancer Cell 2011;19:401e15.
27. Jemal A, Murray T, Samuels A, et al. Cancer statistics, 2003. CA Cancer J Clin 2003;53:5e26.
28. De Jong MC, Pulitano C, Ribero D, et al. Rates and patterns of recurrence following curative intent surgery for colorectal liver metastasis: an international multi-institutional analysis of 1669 patients. Ann Surg 2009;250:440e8.
29. Bohle B, Pera M, Pascual M, et al. Postoperative intra-abdominal infection increases angiogenesis and tumor recurrence after surgical excision of colon cancer in mice. Surgery 2010;147:120e6.
30. Miccini M, Borghese O, Scarpini M, et al. Anastomotic leakage and septic complications: impact on local recurrence in surgery of low rectal cancer. Ann Ital Chir 2011;82:117e23.
31. Mirnezami A, Mirnezami R, Chandrakumaran K, et al. Increased local recurrence and reduced survival from colorectal cancer following anastomotic leak: systematic review and meta-analysis. Ann Surg 2011;253:890e9.
32. McMillan D, Wotherspoon H, Fearon K, et al. A prospective study of tumor recurrence and the acute-phase response after apparently curative colorectal cancer surgery. Am J Surg 1995;170:319e22.
33. Murthy SM, Goldschmidt RA, Rao LN, et al. The influence of surgical trauma on experimental metastasis. Cancer 1989;64:2035e44.
34. Georges C, Lo T, Alkofer B, et al. The effects of surgical trauma on colorectal liver metastasis. Surg Endosc 2007;21:1817e19.
35. Raa ST, Oosterling SJ, Van Der Kaaij NP, et al. Surgery promotes implantation of disseminated tumor cells, but does not increase growth of tumor cell clusters. J Surg Oncol 2005;92:124e9.
36. Van Der Bij GJ, Oosterling SJ, Bogels M, et al. Blocking alpha2 integrins on rat CC531s colon carcinoma cells prevents operationinduced augmentation of liver metastases outgrowth. Hepatology 2008;47:532e43.
37. Van Den Tol PM, Van Rossen EE, Van Eijck CH, et al. Reduction of peritoneal trauma by using nonsurgical gauze leads to less implantation metastasis of spilled tumor cells. Ann Surg 1998;227:242e8.
38. Gutt CN, Riemer V, Kim ZG, et al. Impact of laparoscopic colonic resection on tumour growth and spread in an experimental model. Br J Surg 1999;86:1180e4.
39. Bouvy ND, Marquet RL, Jeekel J, et al. Laparoscopic surgery is associated with less tumour growth stimulation than conventional surgery: an experimental study. Br J Surg 1997;84:358e61.
40. Da Costa ML, Redmond HP, Finnegan N, et al. Laparotomy and laparoscopy differentially accelerate experimental flank tumour growth. Br J Surg 1998;85:1439e42.
41. Pera M, Nelson H, Rajkumar SV, et al. Influence of postoperative acute-phase response on angiogenesis and tumor growth: open vs. laparoscopic-assisted surgery in mice. J Gastrointest Surg 2003;7:783e90.
42. Mutter D, Hajri A, Tassetti V, et al. Increased tumor growth and spread after laparoscopy vs laparotomy: influence of tumor manipulation in a rat model. Surg Endosc 1999;13:365e70.
43. Chen WS, Chung MY, Liu JH, et al. Impact of circulating free tumor cells in the peripheral blood of colorectal cancer patients during laparoscopic surgery. World J Surg 2004;28:552e7.
44. Lacy AM, García-Valdecasas JC, Delgado S, et al. Laparoscopyassisted colectomy versus open colectomy for treatment of nonmetastatic colon cancer: a randomised trial. Lancet 2002;359:2224e9.
45. Lacy AM, Delgado S, Castells A, et al. The long-term results of a randomized clinical trial of laparoscopy-assisted versus open surgery for colon cancer. Ann Surg 2008;248:1e7.
46. Pascual M, Alonso S, Paŕes D, et al. Randomized clinical trial comparing inflammatory and angiogenic response after open versus laparoscopic curative resection for colonic cancer. Br J Surg 2011;98:50e9.
47. Baumann H, Gauldie J. The acute phase response. Immunol Today 1994;15:74e80.
48. Baigrie RJ, Lamont PM, Kwiatkowski D, et al. Systemic cytokine response after major surgery. Br J Surg 1992;79:757e60.
49. Desborough JP. The stress response to trauma and surgery. Br J Anaesth 2000;85:109e17.
50. Roumen RM, Van Der Vliet JA, Wevers RA, et al. Intestinal permeability is increased after major vascular surgery. J Vasc Surg 1993;17:734e7.
51. Rush BF. Irreversibility in hemorrhagic shock is caused by sepsis. Am Surg 1989;55:204e8.
52. Ayala A, Meldrum DR, Perrin MM, et al. The release of transforming growth factor-beta following haemorrhage: its role as a mediator of host immunosuppression. Immunology 1993;79:479e84.
53. Bondestam J, Salven P, Jä̈askela-Saari H, et al. Major surgery increases serum levels of vascular endothelial growth factor only temporarily. Am J Surg 2000;179:57e9.
54. Wagatsuma A. Endogenous expression of angiogenesis-related factors in response to muscle injury. Mol Cell Biochem 2007;298:151e9.
55. Van Meurs M, K̈umpers P, Ligtenberg JJ, et al. Bench-tobedside review: angiopoietin signalling in critical illness - a future target? Crit Care 2009;13:207.
56. Cohen T, Nahari D, Cerem L, et al. Interleukin 6 induces the expression of vascular endothelial growth factor. J Biol Chem 1996;271:736e41.
57. Akagi Y, Liu W, Xie K, et al. Regulation of vascular endothelial growth factor expression in human colon cancer by interleukin-1b. Br J Cancer 1999;80:1506e11.
58. Jee S, Shen S, Chin H, et al. Overexpression of interleukin-6 in human basal cell carcinoma cell lines increases anti-apoptotic activity and tumorigenic potency. Oncogene 2001;11:198e208.
59. Bentes De Souza AM, Rogers MS, Wang CC, et al. Comparison of peritoneal oxidative stress during laparoscopy and laparotomy. J Am Assoc Gynecol Laparosc 2003;10:65e74.
60. Yukioka T, Tanaka H, Ikegami K, et al. Free radicals and surgical stress. Nihon Geka Gakkai Zasshi 1996;97:716e20.
61. Mittal A, Phillips AR, Loveday B, et al. The potential role for xanthine oxidase inhibition in major intra-abdominal surgery. World J Surg 2008;32:288e95.
62. Anup R, Aparna V, Pulimood A, et al. Surgical stress and the small intestine: role of oxygen free radicals. Surgery 1999;125:560e9.
63. Thomas S, Pulimood A, Balasubramanian KA. Heat preconditioning prevents oxidative stress-induced damage in the intestine and lung following surgical manipulation. Br J Surg 2003;90:473e81.
64. Menger MD, Vollmar B. Surgical trauma: hyperinflammation versus immunosuppression? Langenbecks Arch Surg 2004;389:475e84.
65. Ushio-Fukai M, Nakamura Y. Reactive oxygen species and angiogenesis: NADPH oxidase as target for cancer therapy. Cancer Lett 2008;266:37e52.
66. Kamata T. Roles of Nox1 and other Nox isoforms in cancer development. Cancer Sci 2009;100:1382e8.
67. De Leo FR, Renee J, McCormick S, et al. Neutrophils exposed to bacterial lipopolysaccharide upregulate NADPH oxidase assembly. J Clin Invest 1998;101:455e63.
68. El Benna J, Faust LP, Babior BM. The phosphorylation of the respiratory burst oxidase component p47phox during neutrophil activation. Phosphorylation of sites recognized by protein kinase C and by proline directed kinases. J Biol Chem 1994;269:23431e6.
69. Byun HS, Won M, Park KA, et al. Prevention of TNF-induced necrotic cell death by rottlerin through a Nox1 NADPH oxidase. Exp Mol Med 2008;40:186e95.
70. Kim YS, Morgan MJ, Choksi S, et al. TNF-induced activation of the Nox1 NADPH oxidase and its role in the induction of necrotic cell death. Mol Cell 2007;26:675e87.
71. Griendling KK, Sorescu D, Ushio-Fukai M. NAD (P) H oxidase: role in cardiovascular biology and disease. Circ Res 2000;86:494e501.
72. Kima HJ, Kimb CH, Ryud JH, et al. Crosstalk between plateletderived growth factor-induced Nox4 activation and MUC8 gene overexpression in human airway epithelial cells. Free Radic Biol Med 2011;50:1039e52.
73. Pendyala S, Usatyuk PV, Gorshkova IA, et al. Regulation of NADPH oxidase in vascular endothelium: the role of phospholipases, protein kinases, and cytoskeletal proteins. Antioxid Redox Signal 2009;11:841e60.
74. Leto TL, Morand S, Hurt D, et al. Targeting and regulation of reactive oxygen species generation by Nox family NADPH oxidases. Antioxid Redox Signal 2009;11:2607-19.
75. Babior BM. NADPH oxidase. Curr Opin Immunol 2004;16:42-7.
76. Cheng G, Cao Z, Xu X, et al. Homologs of gp91phox: cloning and tissue expression of Nox3, Nox4, and Nox5. Gene 2001;269:131-40.
77. Desouki MM, Kulawiec M, Bansal S, et al. Cross talk between mitochondria and superoxide generating NADPH oxidase in breast and ovarian tumors. Cancer Biol Ther 2005;4:1367-73.
78. Wang R, Dashwood WM, Nian H, et al. NADPH oxidase overexpression in human colon cancers and rat colon tumors induced by 2-amino-1-methyl-6- phenylimidazo[4, 5-b]pyridine (PhIP). Int J Cancer 2011;128:2581-90.
79. Brar SS, Kennedy TP, Sturrock AB, et al. An NAD (P) H oxidase regulates growth and transcription in melanoma cells. Am J Physiol Cell Physiol 2002;282:C1212-24.
80. Graham KA, Kulawiec M, Owens KM, et al. NADPH oxidase 4 is an oncoprotein localized to mitochondria. Cancer Biol Ther 2010;10:223-31.
81. Lim SD, Sun C, Lambeth JD, et al. Increased Nox1 and hydrogen peroxide in prostate cancer. Prostate 2005;62:200-7.
82. Lu JP, Monardo L, Bryskin I, et al. Androgens induce oxidative stress and radiation resistance in prostate cancer cells though NADPH oxidase. Prostate Cancer Prostatic Dis 2010;13:39-46.
83. Brar SS, Corbin Z, Kennedy TP, et al. NOX5 NAD (P) H oxidase regulates growth and apoptosis in DU 145 prostate cancer cells. Am J Physiol Cell Physiol 2003;285:C353-69.
84. Rao Malla R, Raghu H, Rao JS. Regulation of NADPH oxidase (Nox2) by lipid rafts in breast carcinoma cells. Int J Oncol 2010;37:1483-93.
85. Ostrakhovitch EA, Li SS. NIP1/DUOXA1 expression in epithelial breast cancer cells: regulation of cell adhesion and actin dynamics. Breast Cancer Res Treat 2010;119:773-86.
86. Edderkaoui M, Nitsche C, Zheng L, et al. NADPH oxidase activation in pancreatic cancer cells is mediated through Aktdependent up-regulation of p22phox. J Biol Chem 2011;286:7779-87.
87. Gianni D, Taulet N, Der Mardirossian C, et al. c-Src-mediated phosphorylation of NoxA1 and Tks4 induces the reactive oxygen species (ROS)-dependent formation of functional invadopodia in human colon cancer cells. Mol Biol Cell 2010;21:4287-98.
88. Bauer KM, Hummon AB, Buechler S. Right-side and left-side colon cancer follow different pathways to relapse. Mol Carcinog. Published Online First: 7 June 2011. doi:10.1002/mc.20804
89. Tominaga K, Kawahara T, Sano T, et al. Evidence for cancer-associated expression of NADPH oxidase 1 (Nox1)-based oxidase system in the human stomach. Free Radic Biol Med 2007;43:1627-38.
90. Yamaura M, Mitsushita J, Furuta S, et al. NADPH oxidase 4 contributes to transformation phenotype of melanoma cells by regulating G2-M cell cycle progression. Cancer Res 2009;69:2647-54.
91. Hong J, Resnick M, Behar J, et al. Acid-induced p16 hypermethylation contributes to development of esophageal adenocarcinoma via activation of NADPH oxidase NOX5-S. Am J Physiol Gastrointest Liver Physiol 2010;299:G697-706.
92. Maranchie JK, Zhan Y. Nox4 is critical for hypoxia-inducible factor 2-alpha transcriptional activity in von Hippel-Lindaudeficient renal cell carcinoma. Cancer Res 2005;65:9190-3.
93. Wang X, Son YO, Chang Q, et al. NADPH oxidase activation is required in reactive oxygen species generation and cell transformation induced by hexavalent chromium. Toxicol Sci 2011;123:399-410.
94. Kolarova H, Bińo L, Pejchalova K, et al. The expression of NADPH oxidases and production of reactive oxygen species by human lung adenocarcinoma epithelial cell line A549. Folia Biol (Praha) 2010;56:211-17.
95. Pelicano H, Carney D, Huang P. ROS stress in cancer cells and therapeutic implications. Drug Resist Updat 2004;7:97-110.
96. Limon-Pacheco J, Gonsebatt ME. The role of antioxidants and antioxidant-related enzymes in protective responses to environmentally induced oxidative stress. Mutat Res 2009;674:137-47.
97. Landriscina M, Maddalena F, Laudiero G, et al. Adaptation to oxidative stress, chemoresistance, and cell survival. Antioxid Redox Signal 2009;11:2701-16.
98. Kekec Y, Paydas S, Tuli A, et al. Antioxidant enzyme levels in cases with gastrointesinal cancer. Eur J Intern Med 2009;20:403-6.
99. Mieyal JJ, Gallogly MM, Qanungo S, et al. Molecular mechanisms and clinical implications of reversible protein S-glutathionylation. Antioxid Redox Signal 2008;10:1941e88.
100. Townsend DM, Tew KD, Tapiero H. The importance of glutathione in human disease. Biomed Pharmacother 2003;57:145e55.
101. Jialal I, Fuller CJ. Effect of vitamin E, vitamin C and betacarotene on LDL oxidation and atherosclerosis. Can J Cardiol 1995;11(Suppl G):97Ge103G.
102. Atrux-Tallau N, Callejon S, Migdal C, et al. Development and in vitro assay of oxidative stress modifying formulations for wound healing promotion. Eur J Dermatol 2011;21(Suppl 2):52e62.
103. Giles NM, Gutowski NJ, Giles GI, et al. Redox catalysts as sensitisers towards oxidative stress. FEBS Lett 2003;535:179e82.
104. Bienert GP, Schjoerring JK, Jahn TP. Membrane transport of hydrogen peroxide. Biochim Biophys Acta 2006;1758:994e1003.
105. Martin KR, Barrett JC. Reactive oxygen species as doubleedged swords in cellular processes: low-dose cell signaling versus high-dose toxicity. Hum Exp Toxicol 2002;21:71e5.
106. McCord JM. Superoxide radical: controversies, contradictions, and paradoxes. Proc Soc Exp Biol Med 1995;209:112e17.
107. Tonks NK. Protein tyrosine phosphatases: from genes, to function, to disease. Nat Rev Mol Cell Biol 2006;7:833e46.
108. Klumpp S, Krieglstein J. Serine/threonine protein phosphatases in apoptosis. Curr Opin Pharmacol 2002;2:458e62.
109. Priulla M, Calastretti A, Bruno P, et al. Preferential chemosensitization of PTEN-mutated prostate cells by silencing the Akt kinase. Prostate 2007;67:782e9.
110. Leslie NR, Bennett D, Lindsay YE, et al. Redox regulation of PI3-kinase signalling via inactivation of PTEN. EMBO J 2003;22:5501e10.
111. Lee SR, Yang KS, Kwon J, et al. Reversible inactivation of the tumor suppressor PTEN by H2O2. J Biol Chem 2002;277:20336e42.
112. Kwon J, Lee SR, Yang KS, et al. Reversible oxidation and inactivation of the tumor suppressor PTEN in cells stimulated with peptide growth factors. Proc Natl Acad Sci U S A 2004;101:16419e24.
113. Meng TC, Fukada T, Tonks NK, et al. Reversible oxidation and inactivation of protein tyrosine phosphatases in vivo. Mol Cell 2002;9:387e99.
114. Bird NC, Mangnall D, Majeed AW. Biology of colorectal liver metastases: a review. J Surg Oncol 2006;94:68e80.
115. Tsuchiya Y, Sawada S, Yoshioka I, et al. Increased surgical stress promotes tumor metastasis. Surgery 2003;133:547e55.
116. Van Rossen ME, Sluiter W, Bonthuis F, et al. Scavenging of reactive oxygen species leads to diminished peritoneal tumor recurrence. Cancer Res 2000;60:5625e9.
117. Niethammer P, Grabher C, Look AT, et al. A tissue-scale gradient of hydrogen peroxide mediates rapid wound detection in zebrafish. Nature 2009;459:996e9.
118. Inokuma T, Haraguchi M, Fujita F, et al. Oxidative stress and tumor progression in colorectal cancer. Hepatogastroenterology 2009;56:343e7.
119. Radisky DC, Levy DD, Littlepage LE, et al. Rac1b and reactive oxygen species mediate MMP-3-induced EMT and genomic instability. Nature 2005;436:123e7.
120. Christiansen JJ, Rajasekaran AK. Reassessing epithelial to mesenchymal transition as a prerequisite for carcinoma invasion and metastasis. Cancer Res 2006;66:8319e26.
121. Linder S. The matrix corroded: podosomes and invadopodia in extracellular matrix degradation. Trends Cell Biol 2007;17:107e17.
122. Buccione R, Caldieri G, Ayala I. Invadopodia: specialized tumor cell structures for the focal degradation of the extracellular matrix. Cancer Metastasis Rev 2009;28:137e49.
123. Bowden ET, Barth M, Thomas D, et al. An invasion-related complex of cortactin, paxillin and PKCmu associates with invadopodia at sites of extracellular matrix degradation. Oncogene 1999;18:4440e9.
124. Coopman PJ, Do MT, Thompson EW, et al. Phagocytosis of cross-linked gelatin matrix by human breast carcinoma cells correlates with their invasive capacity. Clin Cancer Res 1998;4:507e15.
125. Thompson EW, Paik S, Br̈unner N, et al. Association of increased basement membrane invasiveness with absence of estrogen receptor and expression of vimentin in human breast cancer cell lines. J Cell Physiol 1992;150:534e44.
126. Gianni D, Diaz B, Taulet N, et al. Novel p47 (phox)-related organizers regulate localized NADPH oxidase 1 (Nox1) activity. Sci Signal 2009;2:ra52.
127. Gianni D, Taulet N, Zhang H, et al. A novel and specific NADPH oxidase-1 (Nox1) small-molecule inhibitor blocks the formation of functional invadopodia in human colon cancer cells. ACS Chem Biol 2010;5:981e93.
128. Gimona M, Buccione R, Courtneidge SA, et al. Assembly and biological role of podosomes and invadopodia. Curr Opin Cell Biol 2008;20:235e41.
129. Diaz B, Shani G, Pass I, et al. Tks5-dependent, Nox-mediated generation of reactive oxygen species is necessary for invadopodia formation. Sci Signal 2009;2:ra53.
130. Pani G, Giannoni E, Galeotti T, et al. Redox-based escape mechanism from death: the cancer lesson. Antioxid Redox Signal 2009;11:2791e806.
131. Pervaiz S, Clement MV. Superoxide anion: oncogenic reactive oxygen species? Int J Biochem Cell Biol 2007;39:1297e304.
132. Boueiz A, Hassoun PM. Regulation of endothelial barrier function by reactive oxygen and nitrogen species. Microvasc Res 2008;77:26e34.
133. Anup R, Susama P, Balasubramanian KA. Role of xanthine oxidase in small bowel mucosal dysfunction after surgical stress. Br J Surg 2000;87:1094e101.
134. Groth S, Schulze M, Kalthoff H, et al. Adhesion and Rac1-dependent regulation of biglycan gene expression by transforming growth factor-beta. Evidence for oxidative signaling through NADPH oxidase. J Biol Chem 2005;280:33190e9.
135. Deem TL, Cook-Mills JM. Vascular cell adhesion molecule 1 (VCAM-1) activation of endothelial cell matrix metalloproteinases: role of reactive oxygen species. Blood 2004;104:2385e93.
136. Van Grevenstein WM, Aalbers AG, Ten Raa S, et al. Surgeryderived reactive oxygen species produced by polymorphonuclear leukocytes promote tumor recurrence: studies in an in vitro model. J Surg Res 2007;140:115e20.
137. Ten Raa S, Van Grevenstein HM, Ten Kate M, et al. The influence of reactive oxygen species on the adhesion of pancreatic carcinoma cells to the peritoneum. Cell Adh Migr 2007;1:77e83.
138. Hansen E, Wolff N, Knuechel R, et al. Tumor cells in blood shed from the surgical field. Arch Surg 1995;130:387e93.
139. Vermeulen P, Van Den Eynden G, Huget P, et al. Prospective study of intratumoral microvessel density, p53 expression and survival in colorectal cancer. Br J Cancer 1999;79:316e22.
140. Cascinu S, Staccioli M, Gasparini G, et al. Expression of vascular endothelial growth factor can predict event-free survival in stage II colon cancer. Clin Cancer Res 2000;6:2803e7.
141. Folkman J. Tumor angiogenesis: therapeutic implications. N Engl J Med 1971;285:1182e6.
142. Katsabeki-Katsafli A, Kerenidi T, Kostikas K, et al. Serum vascular endothelial growth factor is related to systemic oxidative stress in patients with lung cancer. Lung Cancer 2008;60:271e6.
143. Arbiser JL, Petros J, Klafter R, et al. Reactive oxygen generated by Nox1 triggers the angiogenic switch. Proc Natl Acad Sci U S A 2002;99:715e20.
144. Holmgren L, O'Reilly MS, Folkman J. Dormancy of micrometastases: balanced proliferation and apoptosis in the presence of angiogenesis suppression. Nat Med 1995;1:149e53.
145. Matsumoto T, Claesson-Welsh L. VEGF receptor signal transduction. Sci STKE 2001;2001:re21.
146. Ushio-Fukai M, Tang Y, Fukai T, et al. Novel role of gp91 (phox) - containing NAD (P) H oxidase in vascular endothelial growth factor-induced signaling and angiogenesis. Circ Res 2002;91:1160e7.
147. Xia C, Meng Q, Liu LZ, et al. Reactive oxygen species regulate angiogenesis and tumor growth through vascular endothelial growth factor. Cancer Res 2007;67:10823e30.
148. Grossoni VC, Falbo KB, Kazanietz MG, et al. Protein kinase C delta enhances proliferation and survival of murine mammary cells. Mol Carcinog 2007;46:381e90.
149. Griner EM, Kazanietz MG. Protein kinase C and other diacylglycerol effectors in cancer. Nat Rev Cancer 2007;7:281e94.
150. Kim J, Koyanagi T, Mochly-Rosen D. PKCd activation mediates angiogenesis via NADPH oxidase activity in PC-3 prostate cancer cells. Prostate 2011;71:946e54.
151. Mesquita FS, Dyer SN, Heinrich DA, et al. Reactive oxygen species mediate mitogenic growth factor signaling pathways in human leiomyoma smooth muscle cells. Biol Reprod 2010;82:341e51.
152. Peshavariya H, Dusting GJ, Jiang F, et al. NADPH oxidase isoform selective regulation of endothelial cell proliferation and survival. Naunyn Schmiedebergs Arch Pharmacol 2009;380:193e204.
153. Shono T, Yokoyama N, Uesaka T, et al. Enhanced expression of NADPH oxidase Nox4 in human gliomas and its roles in cell proliferation and survival. Int J Cancer 2008;123:787e92.
154. Tey HB, Khoo HE, Tan CH. Adenosine modulates cell growth in human epidermoid carcinoma (A431) cells. Biochem Biophys Res Commun 1992;187:1486e92.
155. Jajoo S, Mukherjea D, Watabe K, et al. Adenosine A (3) receptor suppresses prostate cancer metastasis by inhibiting NADPH oxidase activity. Neoplasia 2009;11:1132e45.
156. Yamazaki D, Kurisu S, Takenawa T. Regulation of cancer cell motility through actin reorganization. Cancer Sci 2005;96:379e86.
157. Du J, Liu J, Smith BJ, et al. Role of Rac1-dependent NADPH oxidase in the growth of pancreatic cancer. Cancer Gene Ther 2011;18:135e43.
158. Ushio-Fukai M, Alexander RW. Reactive oxygen species as mediators of angiogenesis signaling: role of NAD (P) H oxidase. Mol Cell Biochem 2004;264:85e97.
159. Harfouche R, Malak NA, Brandes RP, et al. Roles of reactive oxygen species in angiopoietin-1/tie-2 receptor signaling. FASEB J 2005;19:1728e30.
160. Ortiz C, Caja L, Sancho P, et al. Biochem Pharmacol 2008;15:1935e45.
161. Verschoor ML, Wilson LA, Singh G. Mechanisms associated with mitochondrial-generated reactive oxygen species in cancer. Can J Physiol Pharmacol 2010;88:204e19.
162. Kabe Y, Ando K, Hirao S, et al. Redox regulation of NF-kappaB activation: distinct redox regulation between the cytoplasm and the nucleus. Antioxid Redox Signal 2005;7:395e403.
163. Myatt SS, Brosens JJ, Lam EW. Sense and sensitivity: FOXO and ROS in cancer development and treatment. Antioxid Redox Signal 2011;14:675e87.
164. Sablina AA, Budanov AV, Ilyinskaya GV, et al. The antioxidant function of the p53 tumor suppressor. Nat Med 2005;11:1306e13.
165. Hayes JD, McMahon M. NRF2 and KEAP1 mutations: permanent activation of an adaptive response in cancer. Trends Biochem Sci 2009;34:176e88.
166. De Nicola GM, Karreth FA, Humpton TJ, et al. Oncogeneinduced Nrf2 transcription promotes ROS detoxification and tumorigenesis. Nature 2011;475:106e9.
167. Siddiqui I A, Adhami VM, Saleem M, et al. Beneficial effects of tea and its polyphenols against prostate cancer. Mol Nutr Food Res 2006;50:130e43.
168. Bianchini F, Vainio H. Wine and resveratrol: mechanisms of cancer prevention? Eur J Cancer Prev 2003;12:417e25.
169. Bjelakovic G, Nikolova D, Gluud LL, et al. Mortality in randomized trials of antioxidant supplements for primary and secondary prevention: systematic review and meta-analysis. JAMA 2007;297:842e57.
170. Bjelakovic G, Nikolova D, Simonetti RG, et al. Antioxidant supplements for prevention of gastrointestinal cancers: a systematic review and meta-analysis. Lancet 2004;364:1219e28.
171. Salim AS. Oxygen-derived free-radical scavengers prolong survival in gastric cancer. Chemotherapy 1992;38:135e44.
172. Salim AS. Scavengers of oxygen-derived free radicals prolong survival in advanced colonic cancer. Tumour Biol 1993;14:9e17.
173. Hyoudou K, Nishikawa M, Kobayashi Y, et al. SOD derivatives prevent metastatic tumor growth aggravated by tumor removal. Clin Exp Metastasis 2008;25:531e6.
174. Hyoudou K, Nishikawa M, Kobayashi Y, et al. Inhibition of peritoneal dissemination of tumor cells by cationized catalase in mice. J Control Release 2007;119:121e7.
175. Hyoudou K, Nishikawa M, Ikemura M, et al. Cationized catalaseloaded hydrogel for growth inhibition of peritoneally disseminated tumor cells. J Control Release 2007;122:151e8.
176. Nishikawa M, Tamada A, Hyoudou K, et al. Inhibition of experimental hepatic metastasis by targeted delivery of catalase in mice. Clin Exp Metastasis 2004;21:213e21.
177. Hyoudou K, Nishikawa M, Kobayashi Y, et al. PEGylated catalase prevents metastatic tumor growth aggravated by tumor removal. Free Radic Biol Med 2006;41:1449e58.
178. Nishikawa M, Hashida M, Takakura Y. Catalase delivery for inhibiting ROS-mediated tissue injury and tumor metastasis. Adv Drug Deliv Rev 2009;61:319e26.
179. Nishikawa M, Hyoudou K, Kobayashi Y, et al. Inhibition of metastatic tumor growth by targeted delivery of antioxidant enzymes. J Control Release 2005;109:101e7.
180. Nishikawa M, Hashida M. Inhibition of tumour metastasis by targeted delivery of antioxidant enzymes. Expert Opin Drug Deliv 2006;3:355e69.
181. Aldieri E, Riganti C, Polimeni M, et al. Classical inhibitors of NOX NAD (P) H oxidases are not specific. Curr Drug Metab 2008;9:686e96.